Skip to content

Company

Viking Therapeutics

VKTX · United States

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold Viking Therapeutics?

Held by 91 covered funds. Sorted by Viking Therapeutics’ share of each fund. Holdings as of each fund’s latest SEC filing.

FundShare of fund
OZEMRoundhill GLP-1 & Weight Loss5.9%
THNRAmplify Weight Loss Drug & Treatment5.5%
WGMCXWasatch Ultra Growth Fund2.5%
SBIOALPS Medical Breakthroughs2.4%
FORHFormidable1.7%
XBIState Street(R) SPDR(R) S&P(R) Biotech1.3%
DSCIXDana Epiphany Small Cap Equity Fund1.1%
WDNAWisdomTree BioRevolution Fund0.9%
AGEAXWater Island Event-Driven Fund0.8%
MIDAmerican Century Mid Cap Growth Impact0.8%
EVNTAltShares Event-Driven0.8%
BBCVirtus LifeSci Biotech Clinical Trials0.7%
NIXTResearch Affiliates Deletions0.6%
WGLSXWasatch Long/Short Alpha Fund0.6%
HRTSTema Heart & Health0.5%
DUNKDana Unconstrained Equity0.4%
FXHFirst Trust Health Care Alphadex Fund0.4%
FMEDFidelity Disruptive Medicine0.3%
ESSCEventide Small Cap0.3%
PWSPacer WealthShield0.2%
FSOPXFidelity Series Small Cap Opportunities Fund0.2%
TMFXMotley Fool Next Index0.2%
STXKStrive Small-Cap0.2%
ISMDInspire Small/Mid Cap0.2%
JHSCJohn Hancock Multifactor Small Cap0.2%
BKSEBNY Mellon US Small Cap Core Equity0.2%
FFSMFidelity Fundamental Small-Mid Cap0.1%
DFSCXU.S. Micro Cap Portfolio0.1%
BBSCJPMorgan BetaBuilders U.S. Small Cap Equity0.1%
RFLRInnovator U.S. Small Cap Managed Floor0.1%
VBKVanguard Small-Cap Growth Index Fund0.1%
MFIGMotley Fool Innovative Growth Factor0.1%
SCDSJPMorgan Fundamental Data Science Small Core0.1%
FFFFounders 1000.1%
MCDSJPMorgan Fundamental Data Science Mid Core0.1%
SCHASchwab U.S. Small-Cap0.1%
FIDGXFidelity Small Cap Growth Fund0.1%
EQALInvesco Russell 1000 Equal Weight0.1%
FOCSXFidelity Small Cap Growth K6 Fund0.1%
ISCViShares Morningstar Small-Cap Value0.1%
IYHiShares U.S. Healthcare0.1%
ISCBiShares Morningstar Small-Cap0.1%
VHTVanguard Health Care Index Fund0.1%
ESMLiShares ESG Aware MSCI USA Small-Cap0.1%
VXFVanguard Extended Market Index Fund0.1%
VBVanguard Small-Cap Index Fund0.1%
ISCGiShares Morningstar Small-Cap Growth0.1%
SSMHXState Street Small/mid Cap Equity Index Portfolio0.1%
FHLCFidelity MSCI Health Care Index0.1%
IWSiShares Russell Mid-Cap Value0.0%
ENHUiShares Enhanced Large Cap Core Active0.0%
IWRiShares Russell Mid-Cap0.0%
WSMLiShares MSCI World Small-Cap0.0%
REMCColumbia Research Enhanced Mid Cap0.0%
SMLFiShares U.S. Small-Cap Equity Factor0.0%
PRFZInvesco Rafi US 1500 Small-Mid0.0%
CFSLXColumn Small Cap Fund0.0%
MSSMMorgan Stanley Pathway Small-Mid Cap Equity0.0%
AVIEAvantis Inflation Focused Equity0.0%
IWDiShares Russell 1000 Value0.0%
ONEQFidelity Nasdaq Composite Index0.0%
GVUSGoldman Sachs MarketBeta(R) Russell 1000 Value Equity0.0%
DFASDimensional U.S. Small Cap0.0%
VONVVanguard Russell 1000 Value Index Fund0.0%
REVSColumbia Research Enhanced Value0.0%
IWPiShares Russell Mid-Cap Growth0.0%
ITOTiShares Core S&P Total U.S. Stock Market0.0%
ESGVVanguard ESG U.S. Stock0.0%
GTPEGoldman Sachs MSCI World Private Equity Return Tracker0.0%
IWBiShares Russell 10000.0%
VITPXVanguard Institutional Total Stock Market Index Fund0.0%
VTIVanguard Total Stock Market Index Fund0.0%
KCXSXKnights of Columbus U.S. ALL CAP INDEX FUND0.0%
IWViShares Russell 30000.0%
TILTFlexShares Morningstar US Market Factor Tilt Index Fund0.0%
SCHBSchwab U.S. Broad Market0.0%
RECSColumbia Research Enhanced Core0.0%
VTHRVanguard Russell 3000 Index Fund0.0%
VONEVanguard Russell 1000 Index Fund0.0%
SSBIXState Street Balanced Index Fund0.0%
VTCIXVanguard Tax-Managed Capital Appreciation Fund0.0%
MSLCMorgan Stanley Pathway Large Cap Equity0.0%
VTVanguard Total World Stock Index Fund0.0%
ACIMSPDR(R) Portfolio MSCI Global Stock Market0.0%
DFUSDimensional U.S. Equity Market0.0%
GGUSGoldman Sachs MarketBeta(R) Russell 1000 Growth Equity0.0%
DCORDimensional US Core Equity 10.0%
IWFiShares Russell 1000 Growth0.0%
VONGVanguard Russell 1000 Growth Index Fund0.0%
DFAUDimensional US Core Equity Market0.0%
DFACDimensional U.S. Core Equity 20.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest Viking Therapeutics news